OpGen

OpGen Debt / Assets

The Debt-to-Assets Ratio of OpGen (OPGN) as of Oct 19, 2026 is 0.05. In the previous year, Debt-to-Assets Ratio was 6.93 — a change of -99.30% (lower).

Debt / Assets

0.05

YoY

-99.30%

Last updated:

Debt-to-Assets Ratio of OpGen is 2025 0.05 . Debt-to-Assets Ratio of OpGen was 2024 6.93 . It decreases by -99.30% lower compared to the previous year.

The OpGen Debt / Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt / Assets
Date
Debt / Assets
Jan 1, 2017
0.20 USD
Jan 1, 2018
0.21 USD
Jan 1, 2019
0.46 USD
Jan 1, 2020
0.46 USD
Jan 1, 2021
0.35 USD
Jan 1, 2022
0.57 USD
Jan 1, 2023
6.93 USD
Jan 1, 2025
0.05 USD
The OpGen Debt / Assets history
YEARDebt / AssetsYoY
0.05-99.30%
6.93+1,106.27%
0.57+63.51%
0.35-23.50%
0.46+0.63%
0.46+115.51%
0.21+8.18%
0.20+29.82%
0.15+27.35%
0.12-90.30%
1.22—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OpGen Stock analysis

What does OpGen do? OpGen Inc is a biotechnology company based in Gaithersburg, Maryland, operating within the Health Care sector. The company went public on May 5, 2015, with ticker OPGN and ISIN US68373L5057. It currently employs three people. OpGen develops molecular information solutions focused on combating infectious diseases in global healthcare settings. The company's technology involves DNA tests and bioinformatics to address antibiotic resistance, assisting healthcare providers in managing patient care decisions and monitoring the spread of multidrug-resistant microorganisms. Its solutions aim to guide clinicians with information about life-threatening infections and help manage patient outcomes. The company's website is http://opgen.com/. OpGen is engaged in creating tools to help protect the hospital biome through customized screening and surveillance. The firm markets its high-resolution DNA tests under the Acuitas trade name. The company has a global network of customers and partners. OpGen does not provide specific details on its product names beyond Acuitas, and no additional financial figures or historical data are available in the provided information. OpGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OpGen stock

Debt-to-Assets Ratio of OpGen is 0.05 in 2025.

Debt-to-Assets Ratio of OpGen changed from 6.93 to 0.05, representing a -99.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt-to-Assets Ratio OpGen since 2006 – with annual values, charts, and detailed analysis.

The Debt-to-Assets ratio measures what percentage of a company's assets are financed through debt. Higher ratios indicate greater financial risk.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt-to-Assets Ratio's OpGen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — OpGen

All Key Metrics — OpGen